152 related articles for article (PubMed ID: 9137991)
21. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT
J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
[TBL] [Abstract][Full Text] [Related]
22. Plasma interleukin-18 levels in chronic renal failure and continuous ambulatory peritoneal dialysis.
Chiang CK; Hsu SP; Pai MF; Peng YS; Ho TI; Liu SH; Hung KY; Tsai TJ; Hsieh BS
Blood Purif; 2005; 23(2):144-8. PubMed ID: 15677863
[TBL] [Abstract][Full Text] [Related]
23. Impaired initial cell reaction in CAPD-related peritonitis.
Koopmans JG; Boeschoten EW; Pannekeet MM; Betjes MG; Zemel D; Kuijper EJ; Krediet RT
Perit Dial Int; 1996; 16 Suppl 1():S362-7. PubMed ID: 8728224
[TBL] [Abstract][Full Text] [Related]
24. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
Maksić D; Colić M; Stanković-Popović V; Radojević M; Bokonjić D
Med Pregl; 2007; 60 Suppl 2():53-7. PubMed ID: 18928158
[TBL] [Abstract][Full Text] [Related]
25. Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis.
Goldman M; Vandenabeele P; Moulart J; Amraoui Z; Abramowicz D; Nortier J; Vanherweghem JL; Fiers W
Nephron; 1990; 56(3):277-80. PubMed ID: 2077410
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
27. Peritoneal macrophages from patients on CAPD show an increased capacity to secrete interleukin-1 beta during peritonitis.
Fieren MW; van den Bemd GJ; Bonta IL
Adv Perit Dial; 1990; 6():120-2. PubMed ID: 1982787
[TBL] [Abstract][Full Text] [Related]
28. Prospective comparison of blood and peritoneal lymphocytes from continuous ambulatory peritoneal dialysis patients.
Lewis SL; Bonner PN; Cooper CL; Holmes CJ
J Clin Lab Immunol; 1992 Jan; 37(1):3-19. PubMed ID: 1339234
[TBL] [Abstract][Full Text] [Related]
29. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.
Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT
J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393
[TBL] [Abstract][Full Text] [Related]
30. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis.
Lai KN; Lai KB; Lam CW; Chan TM; Li FK; Leung JC
Am J Kidney Dis; 2000 Apr; 35(4):644-52. PubMed ID: 10739785
[TBL] [Abstract][Full Text] [Related]
31. High Intraperitoneal Interleukin-6 Levels Predict Peritonitis in Peritoneal Dialysis Patients: A Prospective Cohort Study.
Yang X; Tong Y; Yan H; Ni Z; Qian J; Fang W
Am J Nephrol; 2018; 47(5):317-324. PubMed ID: 29779030
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
[TBL] [Abstract][Full Text] [Related]
33. [A rare cause of peritoneal dialysis-related peritonitis: Haemophilus influenzae].
Unal A; Perçin DE; Sipahioğlu MH; Kavuncuoğlu F; Tokgöz B; Oymak O; Utaş C
Mikrobiyol Bul; 2009 Jul; 43(3):477-80. PubMed ID: 19795624
[TBL] [Abstract][Full Text] [Related]
34. Fas expression on peritoneal macrophages during continuous ambulatory peritoneal dialysis peritonitis.
Chen CY; Wu CY; Tsai TC; Lin WT; Lee WJ; Su CC; Chen HC; Chiang HC
Ren Fail; 2008; 30(3):297-301. PubMed ID: 18350449
[TBL] [Abstract][Full Text] [Related]
35. Intraperitoneal interleukin-8 and neutrophil influx in the initial phase of a CAPD peritonitis.
Betjes MG; Visser CE; Zemel D; Tuk CW; Struijk DG; Krediet RT; Arisz L; Beelen RH
Perit Dial Int; 1996; 16(4):385-92. PubMed ID: 8863332
[TBL] [Abstract][Full Text] [Related]
36. Increased production of hyaluronan by peritoneal cells and its significance in patients on CAPD.
Lai KN; Szeto CC; Lai KB; Lam CW; Chan DT; Leung JC
Am J Kidney Dis; 1999 Feb; 33(2):318-24. PubMed ID: 10023645
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory effects of peritoneal dialysis: evidence of systemic monocyte activation.
Libetta C; De Nicola L; Rampino T; De Simone W; Memoli B
Kidney Int; 1996 Feb; 49(2):506-11. PubMed ID: 8821837
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
Brauner A; Hylander B; Wretlind B
Am J Kidney Dis; 1996 Mar; 27(3):402-8. PubMed ID: 8604710
[TBL] [Abstract][Full Text] [Related]
39. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis have an increased capability to release tumour necrosis factor during peritonitis.
Fieren MW; van den Bemd GJ; Bonta IL; Ben-Efraim S
J Clin Lab Immunol; 1991 Jan; 34(1):1-9. PubMed ID: 1667936
[TBL] [Abstract][Full Text] [Related]
40. Bacterial peritonitis and beta-2 microglobulin (B2M) production by peritoneal macrophages (PM0) in CAPD patients.
Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Canepa M; Zanin T; Cantaluppi A; Salit M
Adv Perit Dial; 1990; 6():106-9. PubMed ID: 1982784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]